IP Verse

Botti & Ferrari patent opposition analysis

The comprehensive analysis of Botti & Ferrari opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Botti & Ferrari

Stay updated with the latest patent oppositions filed by Botti & Ferrari

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4294395
Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-0077GENENTECHDec 29, 2025BOTTI & FERRARI
EP3615541
Polymorphs And Solid Forms Of (S)-2-((2-((S)-4-(Difluoromethyl)-2-Oxooxazolidin-3-Yl)-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepin-9-Yl)Amino)Propanamide, And Methods Of ProductionF HOFFMANN LA ROCHEDec 19, 2025BOTTI & FERRARI
EP3246047
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025BOTTI & FERRARI
EP4069254
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICALJun 11, 2025BOTTI & FERRARI
EP3595667
Pharmaceutical Compositions Comprising A Jak InhibitorGILEAD SCIENCESSep 17, 2024BOTTI & FERRARI
EP3526170
Method For Producing Mineral FibresSAINT GOBAINSep 6, 2024STM
EP2497650
Method For Processing A Structured Surface Of An Embossing ToolHUECK RHEINISCHEJul 11, 2024SESA
EP3500241
Combination Therapy For CopdCHIESI FARMACEUTICIJul 3, 2024BOTTI & FERRARI
EP3634463
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 26, 2024BOTTI & FERRARI
EP3307271
Methods Of Using Pyruvate Kinase ActivatorsAGIOS PHARMACEUTICALSJun 11, 2024BOTTI & FERRARI

Top clients of Botti & Ferrari

Top companies who are the clients of Botti & Ferrari

CompanyTotal
BOTTI & FERRARI12
STM6
SESA1